leadf
logo-loader
viewProPhase Labs
(
NASDAQ:PRPH
)

ProPhase Labs presents at Proactive's One2One virtual investor forum

ProPhase Labs, Inc (NASDAQ:PRPH) CEO Ted Karkus presents at Proactive's One2One virtual investor forum.

ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The company said its testing integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of not only COVID-19 but also its viral mutations, as well as Influenza A, B, and more.

Quick facts: ProPhase Labs

Follow
NASDAQ:PRPH

Price: 5.16 USD

Market Cap: $78.2 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

ProPhase Labs CEO says its coronavirus testing labs have a 24 hr turnaround,...

ProPhase Labs Inc (NASDAQ:PRPH) CEO Ted Karkus tells Proactive the company's coronavirus testing facilities which recently closed $37,500,000 to help fund the demand its been experiencing for its tests, has a 24 hour turnaround time that can beat out its larger competitors in the...

on 01/29/2021

2 min read